Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. [electronic resource]
- Pharmacology 2012
- 223-32 p. digital
Publication Type: Journal Article
1423-0313
10.1159/000342380 doi
Animals Asthma--blood Bronchial Hyperreactivity--drug therapy Chronic Disease Eosinophilia--blood Female Fibrinogen--analysis Humans Interleukin-5--biosynthesis Male Naphthyridines--therapeutic use Phosphodiesterase 4 Inhibitors--therapeutic use Rats Rats, Inbred BN Rats, Inbred F344 Tumor Necrosis Factor-alpha--biosynthesis